“中国首个建立完整mRNA疫苗研发体系”的龙头企业艾美疫苗再传利好!3月23日艾美疫苗发布公告称,mRNA带状疱疹疫苗已于近日获得美国药监局(FDA)临床试验许可。在临床前试验中,第三方检测单位的检测结果显示:这款疫苗特异性T细胞免疫、特异性IgG抗体滴度、膜抗原荧光抗体(FAMA) 滴度,均显著高于国际市售重组亚单位对照疫苗。艾美mRNA疫苗技术平台再获国际权威机构认可继mRNA RSV疫苗美国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.